Maryam Pourmaleki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maryam Pourmaleki has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Ingo K. Mellinghoff
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, USA
102 shared publications - Nicholas D. Socci
Bioinformatics Core, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York
102 shared publications - Caitlin J. Jones
Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York. 4
92 shared publications - Travis J. Hollmann
Memorial Sloan Kettering Cancer Center
71 shared publications - Andrea Schietinger
Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA
69 shared publications - Carl Campos
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. 1
69 shared publications
Latest Publications
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S1-S2 from Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology
Supplementary Table S1: Overview of multiplexed antibody-based imaging technologies.Supplementary Table S2: Application of multiplexed antibody-based imaging in cancer research.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S1-S2 from Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology
Supplementary Table S1: Overview of multiplexed antibody-based imaging technologies.Supplementary Table S2: Application of multiplexed antibody-based imaging in cancer research.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Data from Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology
Summary:The shift in cancer therapy from broadly cytotoxic agents toward “personalized” treatments that target specific alterations in each patient's tumor requires diagnostic pathology approaches that are quantitative and biospecimen-friendly. Novel multiplexed antibody-based imaging technologies can measure single-cell expression of over 60 proteins in intact tumor sections and hold promise for clinical oncology.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology
Summary:The shift in cancer therapy from broadly cytotoxic agents toward “personalized” treatments that target specific alterations in each patient's tumor requires diagnostic pathology approaches that are quantitative and biospecimen-friendly. Novel multiplexed antibody-based imaging technologies can measure single-cell expression of over 60 proteins in intact tumor sections and hold promise for clinical oncology.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S8. B2M/MHCI/MHCII/PDL1-related HRS cell neighborhoods.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S8. B2M/MHCI/MHCII/PDL1-related HRS cell neighborhoods.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S8. Comparison of EBV-positive and EBV-negative cHL.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S8. Comparison of EBV-positive and EBV-negative cHL.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S9. Gene expression landscape of EBV-related cHL.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S9. Gene expression landscape of EBV-related cHL.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S12 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S12. HRS cell aggregates.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S12 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S12. HRS cell aggregates.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S2. Tracking of cell loss across staining cycles.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S2. Tracking of cell loss across staining cycles.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S10. Quantification of HRS cell patterns of spatial organization.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S10. Quantification of HRS cell patterns of spatial organization.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S5. Cell count, cell loss, and field of view count for each patient.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S5. Cell count, cell loss, and field of view count for each patient.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S1. Validation of mpIF antibody panel.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S1. Validation of mpIF antibody panel.